International Journal on Magnetic Particle Imaging IJMPI
Vol. 12 No. 1 Suppl 1 (2026): Int J Mag Part Imag
Short Abstracts, ID 938
Coagulation Induced MPS-Signal Changes in Human Blood Samples
Main Article Content
Copyright (c) 2026 Maria-Josephina Buhné, Justin Ackers, Mandy Ahlborg , Matthias Graeser, Throsten Buzug , Kerstin Lüdtke-Buzug , Tobias Knopp, Jonas Stroeder , Jörg Barkhausen, Roman Kloeckner, Alex Frydrychowicz, Franz Wegner, Eric Aderhold

This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
With the clinical approval of the MRI contrast agent Resotran and the development of first human-scale Magnetic Particle Imaging (MPI) scanners, clinical applications of MPI are within reach. Magnetic Particle Spectroscopy (MPS), the non-imaging counterpart of MPI, allows for highly sensitive analysis by utilizing the signal responses of magnetic nanoparticles. The use of MPS as point-of-care (PoC) devices and -applications is very advantageous. In this study, we evaluate the potential of MPS to monitor blood coagulation in real time.
Article Details
References
[2] E. U. Saritas et al., “Magnetic Particle Imaging (MPI) for NMR and MRI researchers,” J. Magn. Reson., vol. 229, pp. 116–126, Apr. 2013, doi: 10.1016/j.jmr.2012.11.029.
[3] P. Vogel et al., “Critical Offset Magnetic Particle SpectroScopy for rapid and highly sensitive medical point-of-care diagnostics,” Nat. Commun., vol. 13, no. 1, p. 7230, Nov. 2022, doi: 10.1038/s41467-022-34941-y.